The tariff classification of Icatibant Injection in dosage form, from Italy
Reasoning
The tariff classification of Icatibant Injection in dosage form, from Italy
Cite this ruling
CBP Ruling N307264 (3004909290): The tariff classification of Icatibant Injection in dosage form, from Italy
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
Protest 1101-00-100042; ZD 1839 tablets
The tariff classification of Abacavir Sulfate (CAS-188062-50-2), imported in bulk form, and Ziagen™ (abacavir sulfate) tablets and Ziagen™ (abacavir sulfate) Oral Solution, from various countries, including the United Kingdom, France, Italy, Canada, and Singapore
The tariff classification of Naratriptan Hydrochloride (CAS-143388-64-1), imported in bulk form, and AMERGE® (naratriptan hydrochloride) tablets, from various countries, including the United Kingdom, France, Italy, Canada, and Singapore
The tariff classification of Zanamivir (CAS-139110-80-8), imported in bulk form, and RELENZA® (zanamivir for inhalation), from the United Kingdom, France, Italy, Canada, Singapore, etc.
Protest 4909-99-100036; Prucalopride succinate tablets